Gain detailed insights into the trading activity of Congress members for Celanese on our government trades page. Stay updated on how elected officials are investing in CE.

Celanese - Government Trades

Celanese

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Oil,Refineries,And,Chemical,Plants,In,Industrial,Areas

Analyst Color

Government

Regulations

Upgrades

Downgrades

Price Target

Economics

Analyst Ratings

ORGN

BofA analyst Steve Byrne notes turbulent 2025 for chemical industry due to demand, inflation, and Trump&#39;s PFAS policies. The analyst upgraded and downgraded several stocks.

Increased Demand, Trump Administration Risks: Analyst Picks Celanese As Chemical Winner, ADM As Loser For 2025

xr:d:DAFeeIkW91A:2,j:1670940971,t:23032808

News

Markets

Trading Ideas

LULU

MCHP

NFLX

Lululemon To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday

Long Ideas

Pre-Market Outlook

Top 3 Materials Stocks That May Rocket Higher In December

nuclear energy ai

Trump&#39;s stance on nuclear energy has generally been supportive, positioning it as a key element in his energy policies.

Trump&#39;s Fossil Fuel Push May Satisfy AI&#39;s Soaring Energy Demand — But What About Nuclear?

Wall-Street-ai7-1

SMAR

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Wall Street

MATV

Top 3 Materials Stocks That Are Preparing To Pump In Q4

BBWI

MRVI

PLNT

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Equities

Movers

General

Deutsche Bank upgrades Celanese to Buy, citing strong operating leverage and long-term earnings growth potential despite short-term challenges.

Deutsche Bank Upgrades Celanese Stock: Analyst Highlights Strong Leverage, Long-Term Growth

clorox_flickr

BEAM

RVLV

This Clorox Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

reports earnings

Earnings

Celanese Corporation (NYSE:CE) shares are tumbling on Tuesday after the company reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its quarterly dividend.

What&#39;s Going On With Celanese Stock Tuesday?

Celanese Corp

CEA Industries Inc

Creations Inc

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

China Eastern Airlines Corp Ltd ADR

CHINA EVERBRIGHT BANK ORD by China Everbright Bank Co Ltd.

China Everbright Bank Co Ltd

CITYCHAMP WATCH & JEWELLE by Citychamp Watch & Jewellery Group Ltd.

Citychamp Watch & Jewellery Group Ltd

Cebu Air Inc

CANASIA ENERGY CORP by CANASIA ENERGY CORP.

CanAsia Energy Corp

Saltbae Capital Corp

Cecil Bancorp Inc

CECO Environmental Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

Ceres Inc

CEEK VR

UpSnap Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Global X S&P Catholic Values Developed ex-U.S. ETF

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

COMML NATL FINCL CRP MICH by Commercial National Financial Corp (MI)

Commercial National Financial Corp (MI)

ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN

Saba Closed-End Funds ETF

Constellation Energy Corporation - Common Stock

Constellation Energy Corp

CHINA ED GROUP HLDGS LTD by CHINA ED GROUP HLDGS LTD.

China Education Group Holdings Ltd

CERRO GRANDE MINING CORP by Cerro Grande Mining Corp.

Cerro Grande Mining Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

Camber Energy Inc OM PAR $0.001 2022 NEW

COELACANTH ENERGY INC by COELACANTH ENERGY INC

Coelacanth Energy Inc

Camber Energy Inc

CONSOL Energy Inc (New) Com

Cresco Ltd

Celsius - United States Dollar

Celcuity Inc

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Celsius Holdings Inc

CELLCOM ISRAEL LTD ORD by Cellcom Israel, Ltd.

Cellcom Israel Ltd

Cellframe

Celo - United States Dollar

Celer Network - United States Dollar

Centamin PLC

Celularity Inc

PREFERRED COMMERCE INC by Preferred Commerce Inc.

Preferred Commerce Inc

Celexpress Inc

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

ClearBridge MLP & Midstream Fund Inc Com (New)

iShares J.P. Morgan EM Corporate Bond ETF

CEN Biotech Inc

Caravan Energy Corp Ordinary Shares

CareNet Inc

Cenntro Inc

CENNZnet

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

Century Aluminum Co

CEO America Inc

CeCors Inc

Cantor Equity Partners, Inc. - Class A ordinary shares

Cantor Equity Partners Inc

REX Crypto Equity Premium Income ETF

Cantor Equity Partners I, Inc. - Class A Ordinary Shares

Cantor Equity Partners I Inc

CEPS PLC

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Crestwood Equity Partners LP Unit Ltd Partnership Int (New)

CERES INC OM NEW

Cere Network

CERES GLOBAL AG CORP ORD by Ceres Global Ag Corp.

Ceres Global Ag Corp

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

Cerus Corp

Certara Inc

COLOMBIA ENERGY RESOUR by Colombia Energy Resources, Inc.

Colombia Energy Resources Inc

SPDR Series Trust SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF

CES ENERGY SOLUTIONS ORD by CES Energy Solutions Corp.

CES Energy Solutions Corp

Chesser Resources Ltd

CHINESE ESTS HLDGS ORD by Chinese Estates Holdings Ltd.

Chinese Estates Holdings Ltd

CHINESE ESTS HLD UNSP/ADR by Chinese Estates Holdings Ltd.

CES Synergies Inc

Central Securities Corporation Common Stock

Central Securities Corp

CoinEx Token

ACT Energy Technologies Ltd

ACT ENERGY TECHS LTD by ACT Energy Technologies Ltd.

DriveWealth ETF Trust DriveWealth NYSE 100 Index ETF

CAPITAL CITY ENERGY GROUP by Capital City Energy Group, Inc.

21Shares Core Ethereum ETF

CYBER ENVIRO-TECH INC. by Cyber Enviro-Tech Inc.

Cyber Enviro-Tech Inc

CHINA ECOTOURISM GRP NEW by CHINA ECOTOURISM GROUP LTD.

CETUS CAP ACQUISITION CORP L A

CETUS CAP ACQUISITION CORP RT

CETUS CAP ACQUISITION CORP UNIT 1 CL A & 1 WT EXP & 1 RT

CETUS CAP ACQUISITION CORP WT EXP

Cemtrex Inc

Celanese Recommends Shareholders Not To Tender Their Shares In Response To TRC Capital's Offer To Purchase Up To 1.50M Shares At $65.50 Per Share In Cash

The chemical industry could be in for a turbulent 2025 spurred by increased demand, cost inflation and President-elect <a href="https://www.benzinga.com/markets/commodities/24/11/42235640/trumps-energy-policies-poised-to-reshape-oil-gas-market-winners-and-losers-revealed">Donald Trump&#8216;s PFAS policies</a>.
The Chemicals Analyst: Bank of America analyst Steve Byrne released a note covering the chemicals industry on Tuesday, upgrading and downgrading several companies:
<ul>
<li>Archer-Daniels-Midland Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) from Neutral to Underperform, lowering its price target from $63 to $54.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Underperform to Buy, lowering its price target from $95 to $88.</li>
<li>Eastman Chemical Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Neutral to Buy, lowering its price target from $115 to $109.</li>
<li>Element Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) from Buy to Neutral, lowering its price target from $32 to $28.</li>
<li>FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Underperform to Neutral, lowering its price target from $63 to $61.</li>
<li>Olin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) from Neutral to Buy, lowering its price target from $48 to $40.</li>
<li>Origin Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) from Buy to Underperform, lowering its price target from $2.50 to $1.50.</li>
</ul>
Main Takeaways: Agriculture stocks faced a decline in the waning months of 2024, amid market concerns over potential trade policies under President-elect Trump and the impact of rising interest rates linked to the federal deficit. Byrne believes the market has already re-priced higher risk.
The analyst believes chemicals will see increased demand with a caveat.
&#8220;We expect end-market demand to grow this year, although we&#8217;ve pared back expectations, given incremental headwinds from tariff concerns, a strong USD, and higher interest rate expectations, among others,&#8221; Byrne said. &#8220;Still, the U.S. Manufacturing PMI has been surprisingly weak and the risk-reward is skewed positively in our view.&#8221;
Meanwhile, the analyst foresees a return of inflationary pressures on input costs, squeezing margins.
Byrne says Trump&#8217;s election win and a possible &#8220;trade war&#8221; could slow GDP growth and hurt chemical companies&#8217; bottom lines. He notes deregulation and lower corporate taxes as a positive. The analyst suggests that Trump&#8217;s weakening of the EPA could pause certain regulatory initiatives, potentially increasing litigation risks for PFAS manufacturers.
Company Takeaways: Byrne cited declining profitability and increased macroeconomic risk for his Archer-Daniels-Midland downgrade.
The analyst upgraded Celanese&#8217;s stock based on an expected demand recovery, an attractive valuation and potential benefits from shareholder activism.
Eastman Chemical took a severe hit in 2024&#8217;s fourth quarter. Byrne says the market&#8217;s sell-off was &#8220;overdone&#8221; and is optimistic for future revenue and earnings growth.
Byrne downgraded Element Solutions and said there is better opportunity elsewhere. He noted possible currency headwinds.
FMC could face a tough recovery from its struggles in 2024, but Byrne is optimistic that the company&#8217;s EBITDA can rebound. The analyst says market multiples are &#8220;appropriately reflecting risks.&#8221;
Byrne says Olin&#8217;s valuation is &#8220;highly attractive&#8221; due to its high free cash flow yield. The analyst also said the company is insulated from Trump administration risks.
The analyst&#8217;s downgrade of Origin Materials is linked to doubts that the company will be able to license its technology and possible headwinds for sustainable products.
Price Action: Several of the companies showed sharp movement following the analyst&#8217;s note:
<ul>
<li>Archer-Daniels-Midland traded at $51.18, down 1.8%.</li>
<li>Celanese Corporation traded at $71.97, up 6.81%.</li>
<li>Eastman Chemical traded at $91.77, up 2.99%.</li>
<li>FMC Corp traded at $53.16, up 2.17%.</li>
<li>Olin Corp traded at $33.10, up 4.38%.</li>
<li>Origin Materials traded at $1, down 9.9%.</li>
</ul>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42974739/wall-street-rebounds-as-producer-inflation-misses-estimates-tesla-gains-chinese-stocks-rally">Wall Street Rebounds As Producer Inflation Misses Estimates, Tesla Gains, Chinese Stocks Rally</a></li>
</ul>
Photo: dongfang/Shutterstock.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs cut the price target for D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) from $200 to $171. Goldman Sachs analyst Susan Maklari maintained a Buy rating. D.R. Horton shares closed at $138.40 on Monday. <a href="https://www.benzinga.com/quote/DHI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo slashed ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) price target from $134 to $132. Wells Fargo analyst Roger Read maintained an Overweight rating. ConocoPhillips shares closed at $104.23 on Monday. <a href="https://www.benzinga.com/quote/COP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc cut the price target for Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) from $90 to $70. Keybanc analyst John Vinh maintained an Overweight rating. Microchip Technology shares closed at $55.91 on Monday. <a href="https://www.benzinga.com/quote/MCHP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS increased the price target for International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) from $150 to $160. UBS analyst David Vogt maintained a Sell rating. IBM shares closed at $217.40 on Monday. <a href="https://www.benzinga.com/quote/IBM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group boosted KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) price target from $88 to $95. Evercore ISI Group analyst Stephen Kim maintained an Outperform rating. KB Home shares settled at $64.08 on Monday. <a href="https://www.benzinga.com/quote/KBH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) price target from $380 to $415. B of A Securities analyst Andrew Obin maintained a Buy rating. GE Vernova shares closed at $366.81 on Monday. <a href="https://www.benzinga.com/quote/GEV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) price target from $550 to $715. Barclays analyst Kannan Venkateshwar maintained an Underweight rating. Netflix shares closed at $840.29 on Monday.  <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo boosted the price target for Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) from $330 to $350. Wells Fargo analyst Michael Sison upgraded the stock from Equal-Weight to Overweight. Air Products shares settled at $301.74 on Monday. <a href="https://www.benzinga.com/quote/APD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) price target from $95 to $88. B of A Securities analyst Steve Byrne upgraded the stock from Underperform to Buy. Celanese shares closed at $67.38 on Monday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group raised Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) price target from $430 to $445. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Lululemon shares closed at $398.86 on Monday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42965686/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-january">Top 2 Industrials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

B of A Securities analyst Steve Byrne upgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Underperform to Buy and lowers the price target from $95 to $88.

B of A Securities Upgrades Celanese to Buy, Lowers Price Target to $88

Morgan Stanley analyst Vincent Andrews maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $100 to $80.

Morgan Stanley Maintains Equal-Weight on Celanese, Lowers Price Target to $80

Providing a diverse range of perspectives from bullish to bearish, 16 analysts have published ratings on Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) in the last three months.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $104.25, a high estimate of $163.00, and a low estimate of $73.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 24.57%. 
<img src="https://www.benzinga.com/files/images/story/2025/1736280028_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Celanese by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$77.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Celanese's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Celanese's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>Discovering Celanese: A Closer Look</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Key Indicators: Celanese's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Celanese's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -2.75%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.38%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.61%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Celanese's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.45%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Celanese's debt-to-equity ratio stands notably higher than the industry average, reaching 1.83. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Celanese Through 16 Analysts

Piper Sandler analyst Charles Neivert maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Underweight and lowers the price target from $98 to $77.

Piper Sandler Maintains Underweight on Celanese, Lowers Price Target to $77

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has been analyzed by 15 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $106.07, a high estimate of $163.00, and a low estimate of $73.00. Highlighting a 24.81% decrease, the current average has fallen from the previous average price target of $141.07. 
<img src="https://www.benzinga.com/files/images/story/2024/1734634861_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Celanese is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Celanese's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>All You Need to Know About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>A Deep Dive into Celanese's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Celanese faced challenges, resulting in a decline of approximately -2.75% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin is impressive, surpassing industry averages. With a net margin of 4.38%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Celanese's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.45%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 15 Analyst Projections For Celanese

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $122 to $88.

RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $88

Citigroup analyst Patrick Cunningham maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Neutral and lowers the price target from $100 to $73.

Citigroup Maintains Neutral on Celanese, Lowers Price Target to $73

Celanese's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) short percent of float has fallen 8.89% since its last report. The company recently reported that it has 5.07 million shares sold short, which is 7.28% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Celanese Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733855414_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celanese has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celanese's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celanese's peer group average for short interest as a percentage of float is 2.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Celanese's Recent Short Interest

Management

Celanese Names Edward Galante, An Independent Director On Board Since 2013, As Chair Of Board

Celanese Names Scott Richardson, Currently Its COO, As CEO; Lori Ryerkerk Is Stepping Down As Chairman, CEO  And Director At End Of The Year

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul>
<li>On Nov. 11, UBS downgraded the stock from Buy to Neutral and lowered its price target from $161 to $97. The company's stock fell around 10% over the past month and has a <a href="https://www.benzinga.com/quote/CE">52-week low of $68.88</a>.</li>
<li>RSI Value: 25.90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CE Price Action: Shares of Celanese gained 1.6% to close at $70.54 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> latest CE news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png" alt="" class="wp-image-682682" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-768x702.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Dow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 3, Dow announced the appointment of Karen S. Carter as Chief Operating Officer. &#8220;Karen is a proven leader with more than three decades of experience at Dow delivering strong business results,&#8221; said Dow Chair and Chief Executive Officer Jim Fitterling. &#8220;She has an excellent track record of operating discipline, maintaining close relationships with key partners and customers, and driving innovation across the organization. She has successfully led our largest business and played critical leadership roles in other essential business and functional teams within Dow, always with a focus on developing and maintaining high-performing teams.&#8221; The company's stock fell around 9% over the past month and <a href="https://www.benzinga.com/quote/DOW">has a 52-week low </a>of $41.73.</li>
<li>RSI Value: 24.25</li>
<li>DOW Price Action: Shares of Dow fell 0.5% to close at $41.99 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> trend in DOW stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png" alt="" class="wp-image-682687" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-768x709.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">Braskem SA ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</h3>
<ul>
<li>On Sept. 18, UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10. The company's stock fell around 12% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/BAK">low of $4.68</a>.</li>
<li>RSI Value: 24.38</li>
<li>BAK Price Action: Shares of Braskem fell 5.8% to close at $4.82 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1">breakout in BAK shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="895" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png" alt="" class="wp-image-682689" style="width:583px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-768x719.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42380712/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Across the recent three months, 14 analysts have shared their insights on Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.86, a high estimate of $163.00, and a low estimate of $76.00. This current average represents a 24.1% decrease from the previous average price target of $148.69. 
<img src="https://www.benzinga.com/files/images/story/2024/1732042869_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$180.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celanese's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Celanese: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Celanese's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -2.75%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Celanese's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.38%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.61%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Celanese's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.45%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Celanese

Barclays analyst Michael Leithead maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $101 to $88.

Barclays Maintains Equal-Weight on Celanese, Lowers Price Target to $88

President-elect Donald Trump ran on a promise to <a href="https://www.benzinga.com/news/24/09/40703958/trumps-drill-baby-drill-pledge-may-not-deliver-promised-energy-price-cuts-experts-warn">&#8220;drill, baby, drill&#8221;</a> in his second term in office, reflecting his continued support of the fossil fuel industry. His stance on nuclear energy, however, is murky.
What Happened: Following his 2016 election win, Trump <a href="https://www.benzinga.com/news/16/12/8836138/trump-says-we-must-greatly-strengthen-expand-nuclear-capability">called for efforts to strengthen</a> U.S. nuclear energy. During his first term, his administration advanced several nuclear microreactor projects, <a href="https://www.energy.gov/ne/photos/11-accomplishments-trump-administration-advanced-nuclear-energy">according</a> to the Department of Energy.
However, he may have flip-flopped on the issue. In an interview with podcaster Joe Rogan ahead of the Nov. 5 election, Trump seemingly highlighted the dangers of pushing nuclear energy, <a href="https://www.huffpost.com/entry/trump-joe-rogan-nuclear-energy_n_671ec211e4b0448bcdb1e742">according</a> to the Huffington Post.
"They get too big and too complex and too expensive," Trump said. "There's a little danger to nuclear—you know, we had some really bad nuclear."
He then named several nuclear projects that have stalled in recent years.
Robert F. Kennedy Jr., an ally of Trump and a <a href="https://kalshi.com/markets/kxfda/next-fda-administrator">possible</a> Trump appointee, has an anti-nuclear track record, <a href="https://www.utilitydive.com/news/nuclear-energy-sector-mixed-views-second-trump-administration-joe-rogan/732407/">according</a> to Utility Dive.
See Also: <a href="https://www.benzinga.com/personal-finance/24/10/41313947/expert-finds-trumps-tax-proposal-drains-money-from-95-of-households-and-funnels-it-to-the-top-5-">Expert Finds Trump&#8217;s Tax Proposal Drains Money From 95% Of Households And Funnels It To The Top 5%</a>
Why it Matters: A future widespread adoption of nuclear energy <a href="https://www.benzinga.com/news/24/09/41020113/sam-altmans-openai-pushes-biden-administration-for-massive-5gw-data-centers-equivalent-to-output-of">necessitates significant investments</a> in data centers. In turn, data centers require substantially higher amounts of electricity. 
Artificial intelligence is <a href="https://www.benzinga.com/markets/esg/24/08/40589781/power-hungry-ai-revives-interest-in-nuclear-energy-michigan-to-reopen-closed-plant-for-first-time-in">projected to use</a> between 8% and 25% of all U.S. electricity by 2030.
Facts show that President Joe Biden&#8216;s administration produced <a href="https://www.benzinga.com/government/23/10/35240230/us-is-producing-more-oil-under-biden-than-at-any-point-under-the-trump-administration">more oil than Trump&#8217;s previous administration</a>. He also prioritized nuclear as a clean energy source. The one-term president positioned it as a bridge energy source that provides reliable, carbon-free electricity.
The Market Reacts: Regardless of whether he centers nuclear energy as a key part of his domestic agenda, Trump&#8217;s support of deregulation would likely serve as a tailwind.
Shares of Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) have traded up over 13% since Trump&#8217;s election win. Constellation Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CE#NASDAQ">CE</a>) has fared worse, trading down nearly 3%.
Small reactor companies have seen even more pronounced gains. Shares of Nuscale Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) are up over 20%. Meanwhile, Nano Nuclear Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) has shot up over 26%.
The Trump-Nuclear trade has seemingly died down on Monday and Tuesday. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto">Trump&#8217;s Treasury Pick Frontrunner Scott Bessent Could Shift Wall Street, Crypto</a></li>
</ul>


Kathy ManningHouse (D-NC)	$1K - $15K	stock	Sale	Sep 14, 2022	Aug 03, 2022	House
Kathy ManningHouse (D-NC)	$1K - $15K	stock	Purchase	Aug 10, 2022	Jul 20, 2022	House
Dwight EvansHouse (D-PA)	$1K - $15K	stock	Sale	Apr 25, 2022	Mar 30, 2022	House
Tommy TubervilleSenate (R-AL)	$1K - $15K	stock	Sale	Apr 08, 2022	Mar 30, 2022	Senate
John RutherfordHouse (R-FL)	$15K - $50K	stock	Sale	Apr 19, 2022	Mar 16, 2022	House

Government Trades

Celanese Corp

top performing CE trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga